Showing results (201-210 of 319) with videos related to

Sort By:
Pageof 32
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 2019
European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer SurgeryDenis Querleu, François Planchamp, Luis Chiva, et al.
Virchows Archiv : an International Journal of Pathology|December 3, 2024
Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 casesPavel Dundr, Jiří Dvořák, Michaela Krausová, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 2, 2020
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group surveyStefano Greggi, Francesca Falcone, Cono Scaffa, et al.
The Oncologist|September 19, 2025
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancerB J Rimel, Eric Pujade-Lauraine, Kathleen Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2024
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival ResultsGiovanni Scambia, Ricardo Villalobos Valencia, Nicoletta Colombo, et al.
The Lancet. Oncology|December 8, 2014
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trialAmit M Oza, David Cibula, Ana Oaknin Benzaquen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2025
Survival of European adolescents and young adults diagnosed with central nervous system tumours and comparison with younger and older age groups: EUROCARE-6 resultsMartin McCabe, Silvia Rossi, Francesco Cerza, et al.
Pathology|July 27, 2023
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significancePavel Dundr, Nikola Hájková, Michaela Kendall Bártů, et al.
American Journal of Obstetrics and Gynecology|November 25, 2022
Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter studyJiri Slama, Ingo Bernard Runnebaum, Giovanni Scambia, et al.
Gynecologic Oncology|September 2, 2018
The genetic landscape of 87 ovarian germ cell tumorsEls Van Nieuwenhuysen, Pieter Busschaert, Patrick Neven, et al.
Pageof 32